Do barrier dressings reduce cardiac implantable device infection: Protocol for a randomized controlled trial (BARRIER-PROTECT). Posted on December 5th, 2023 by LEADconnection Bookmark Please login to bookmarkClose Username or Email Address Password Remember Me Post navigation Previous: Practical Considerations for Cardiac Electronic Devices Reimplantation Following Transvenous Lead Extraction Due to Related Endocarditis.Next: Reappraisal of [18F]FDG-PET/CT for diagnosis and management of cardiac implantable electronic device infections
Practical Considerations for Cardiac Electronic Devices Reimplantation Following Transvenous Lead Extraction Due to Related Endocarditis. Posted on December 5th, 2023 by LEADconnection Bookmark Please login to bookmarkClose Username or Email Address Password Remember Me Post navigation Previous: Device-related infection and mortality in patients with chronic kidney disease receiving cardiac implantable electronic devices: a propensity score-matched cohort study.Next: Do barrier dressings reduce cardiac implantable device infection: Protocol for a randomized controlled trial (BARRIER-PROTECT).
Device-related infection and mortality in patients with chronic kidney disease receiving cardiac implantable electronic devices: a propensity score-matched cohort study. Posted on December 5th, 2023 by LEADconnection Bookmark Please login to bookmarkClose Username or Email Address Password Remember Me Post navigation Previous: PROFID EHRA trial enrols first patientNext: Practical Considerations for Cardiac Electronic Devices Reimplantation Following Transvenous Lead Extraction Due to Related Endocarditis.